Hikma, West-Ward move to dismiss Walmart's US drug price-fixing claims
( September 3, 2025, 22:59 GMT | Official Statement) -- MLex Summary: Hikma Labs, West-Ward Pharmaceuticals and West-Ward Columbus asked a Pennsylvania federal judge to dismiss generic drug price-fixing claims brought by Walmart. Walmart "seemingly failed to conduct even the most basic of investigations required to demonstrate that its allegations have factual support or are likely to be borne out in discovery," the defendants said in a motion-to-dismiss in the US Eastern District of Pennsylvania.See attached files....
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.